Related Experiment Video
Updated: Jul 24, 2025

Author Spotlight: Investigating Bacteriophage-Induced Immune Responses in Gnotobiotic Mice
Published on: January 26, 2024
Characterization of an Enterococcus faecalis bacteriophage SFQ1 as a potential therapeutic agent
Fuqiang Song1, Jun Sheng2, Jishan Tan1
1Department of Medical Laboratory, The General Hospital of Western Theater Command, Chengdu, China.
Abstract:
Enterococcus faecalis is a well-established resident of the human gastrointestinal tract and is also a major cause of human infections. Unfortunately, therapeutic options for E. faecalis infections remain limited, particularly with the emergence of vancomycin-resistant strains in hospital settings. Consequently, there has been a renewed interest in phage therapy as an alternative to antibiotics. In this study, we have isolated a bacteriophage, vB_EfaS-SFQ1, from hospital sewage, which effectively infects E. faecalis strain EFS01. Phage SFQ1 is a siphovirus and exhibits a relatively broad host range. Furthermore, it has a short latent period of approximately 10 min and a large burst size of about 110 PFU/cell at a multiplicity of infection (MOI) of 0.01, and it could effectively disrupt the biofilms formed by E. faecalis. Thus, this study provides a detailed characterization of E. faecalis phage SFQ1, which has great potential for treating E. faecalis infections.
Insights
A novel bacteriophage, vB_EfaS-SFQ1, effectively infects and disrupts biofilms of Enterococcus faecalis. This phage shows promise as a therapeutic alternative to antibiotics for treating E. faecalis infections.
Area of Science:
- Microbiology
- Virology
- Infectious Diseases
Background:
- Enterococcus faecalis is a common human pathogen, particularly problematic due to vancomycin resistance.
- Limited therapeutic options necessitate alternative treatments for E. faecalis infections.
Purpose of the Study:
- To isolate and characterize a bacteriophage targeting Enterococcus faecalis.
- To evaluate the potential of phage therapy against E. faecalis infections and biofilms.
Main Methods:
- Isolation of bacteriophage vB_EfaS-SFQ1 from hospital sewage.
- Characterization of phage SFQ1, including host range, latent period, and burst size.
- Assessment of phage SFQ1's efficacy in disrupting E. faecalis biofilms.
Main Results:
- Phage vB_EfaS-SFQ1 (SFQ1) was isolated and identified as a siphovirus with a broad host range.
- SFQ1 demonstrated a short latent period (~10 min) and a large burst size (~110 PFU/cell at MOI 0.01).
- SFQ1 effectively disrupted Enterococcus faecalis biofilms.
Conclusions:
- Phage SFQ1 is a potent lytic phage against Enterococcus faecalis.
- SFQ1 exhibits characteristics suitable for phage therapy applications.
- This phage holds significant potential for developing novel treatments for E. faecalis infections.
Related Concept Videos
Lytic Cycle of Bacteriophages
Gene Regulation in Microbial Communities: Quorum Sensing
DNA Bacteriophages
Lysogenic Cycle of Bacteriophages
Viral Replication: Lytic Cycle

